340
Views
15
CrossRef citations to date
0
Altmetric
Review

Emerging oral VEGF inhibitors for the treatment of renal cell carcinoma

, & ORCID Icon
Pages 121-130 | Received 27 Jul 2018, Accepted 11 Dec 2018, Published online: 21 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhan Chen, Yong Zhang, Xiang Wu, Ji Zhang, Wei Xu, Cheng Shen & Bing Zheng. (2021) Gαi1 Promoted Proliferation, Migration and Invasion via Activating the Akt-mTOR/Erk-MAPK Signaling Pathway in Renal Cell Carcinoma. OncoTargets and Therapy 14, pages 2941-2952.
Read now
Mutlu Hizal, Mehmet A. N. Sendur, Burak Bilgin, Muhammed Bulent Akinci, Didem Sener Dede & Bulent Yalcin. (2020) A historical turning point for the treatment of advanced renal cell carcinoma: inhibition of immune checkpoint. Current Medical Research and Opinion 36:4, pages 625-635.
Read now

Articles from other publishers (13)

Huijiao Jiang, Xiaoyi Wang, Lijiao Guo, Xiaowu Tan, Xianwei Gui, Zhenyu Liao, Zhiwei Li, Xueling Chen & Xiangwei Wu. (2023) Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis. Parasites & Vectors 16:1.
Crossref
Shifeng Yang, Boshi Sun, Jiacheng Li, Nana Li, Ange Zhang, Xinyu Zhang, Hao Yang & Xiaoming Zou. (2023) Neutrophil extracellular traps promote angiogenesis in gastric cancer. Cell Communication and Signaling 21:1.
Crossref
Samantha M. Ruff, Alexander H. Shannon & Timothy M. Pawlik. (2023) The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis. Cancers 15:13, pages 3513.
Crossref
Yuan Cao, Chunyun Sun, Guitao Huo, Huiyu Wang, Yong Wu, Fei Wang, Susu Liu, Shijie Zhai, Xiao Zhang, Haoyang Zhao, Meiling Hu, Wenda Gu, Yanwei Yang, Sanlong Wang, Chunnan Liang, Jianjun Lyu, Tiangong Lu, Youchun Wang, Liangzhi Xie & Changfa Fan. (2022) Novel hKDR mouse model depicts the antiangiogenesis and apoptosis‐promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2. Cancer Science 114:1, pages 115-128.
Crossref
Hien Thi My Ong, Tae-Hun Kim, Eda Ates, Jae-Chul Pyun & Min-Jung Kang. (2022) Overexpression of CYP11A1 recovers cell cycle distribution in renal cell carcinoma Caki-1. Cancer Cell International 22:1.
Crossref
Hongjin Shi, Jinze Li, Zhinan Fan, Jing Yang, Shi Fu, Haifeng Wang, Jiansong Wang & Jinsong Zhang. (2022) Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes. Frontiers in Oncology 12.
Crossref
Tobiloba C. Elebiyo, Damilare Rotimi, Ikponmwosa O. Evbuomwan, Rotdelmwa Filibus Maimako, Matthew Iyobhebhe, Oluwafemi Adeleke Ojo, Olarewaju M. Oluba & Oluyomi S. Adeyemi. (2022) Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy. Cancer Treatment and Research Communications 32, pages 100620.
Crossref
Nellowe Candelario, Christopher Geiger & Thomas Flaig. (2021) Sarcomatoid Renal Cell Carcinoma: The Present and Future of Treatment Paradigms. Kidney Cancer 5:4, pages 167-179.
Crossref
Yan Feng, Ying Li, Xinling Yang, Limin Han, Luning Wang, Shan Gao, Ruixue Yin, Xue Wang, Jiayang Li, Meiming Liu & Baiyan Li. (2021) Direct evidence of VEGF-mediated neuroregulation and afferent explanation of blood pressure dysregulation during angiogenic therapy. Frigid Zone Medicine 1:2, pages 119-126.
Crossref
Keiichiro Mori, Hadi Mostafaei, Noriyoshi Miura, Pierre I. Karakiewicz, Stefano Luzzago, Manuela Schmidinger, Andreas Bruchbacher, Benjamin Pradere, Shin Egawa & Shahrokh F. Shariat. (2020) Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis. Cancer Immunology, Immunotherapy 70:2, pages 265-273.
Crossref
Wei Li, Chengguan Feng, Weihong Di, Shanwen Hong, Hui Chen, Mubashir Ejaz, Yang Yang & Tian-rui Xu. (2020) Clinical use of vascular endothelial growth factor receptor inhibitors for the treatment of renal cell carcinoma. European Journal of Medicinal Chemistry 200, pages 112482.
Crossref
Yuan-Hong Xie, Ying-Xuan Chen & Jing-Yuan Fang. (2020) Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy 5:1.
Crossref
Junpeng Wang, Xin Li, Xiaoqiang Wu, Zhiwei Wang, Chan Zhang, Guanghui Cao, Xiaofan Zhang, Feng Peng & Tianzhong Yan. (2019) Role of immune checkpoint inhibitor-based therapies for metastatic renal cell carcinoma in the first-line setting: A Bayesian network analysis. EBioMedicine 47, pages 78-88.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.